A detailed history of Calamos Advisors LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Calamos Advisors LLC holds 26,831 shares of PCVX stock, worth $2.34 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
26,831
Previous 11,533 132.65%
Holding current value
$2.34 Million
Previous $870,000 252.07%
% of portfolio
0.02%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$70.52 - $117.12 $1.08 Million - $1.79 Million
15,298 Added 132.65%
26,831 $3.06 Million
Q2 2024

Jul 25, 2024

BUY
$60.06 - $78.77 $82,162 - $107,757
1,368 Added 13.46%
11,533 $870,000
Q1 2024

May 08, 2024

BUY
$59.79 - $81.05 $607,765 - $823,873
10,165 New
10,165 $694,000

Others Institutions Holding PCVX

About Vaxcyte, Inc.


  • Ticker PCVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,315,100
  • Market Cap $5.17B
  • Description
  • Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...
More about PCVX
Track This Portfolio

Track Calamos Advisors LLC Portfolio

Follow Calamos Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Calamos Advisors LLC with notifications on news.